Bioinformatics-driven insights: rapamycin-mediated CaMK2D inhibition alleviates intestinal ischemia-reperfusion injury - Top-Institutions - MDSpire

Bioinformatics-driven insights: rapamycin-mediated CaMK2D inhibition alleviates intestinal ischemia-reperfusion injury

  • By

  • Ruxiang Sheng

  • Yanqiu Liang

  • Huihong Zhang

  • Yonghe Lai

  • Haiyun Hong

  • Dingbang Huang

  • Dezhao Liu

  • May 1, 2026

  • 0 min

Share

Top Institutions in Oncology

Brief introduction explaining scope and methodology.

  • #1

    Mayo Clinic
    Mayo Clinic

    Rochester, Minnesota

    Key Differentiators

    • Gastroenterology
    • GI Surgery

  • #2

    Cedars-Sinai Medical Center
    Cedars-Sinai Medical Center

    Los Angeles, California

    Key Differentiators

    • Gastroenterology
    • GI Surgery

Original Source(s)

Bioinformatics-driven insights: rapamycin-mediated CaMK2D inhibition alleviates intestinal ischemia-reperfusion injury

  • by Ruxiang Sheng, Yanqiu Liang, Huihong Zhang, Yonghe Lai, Haiyun Hong, Dingbang Huang, Dezhao Liu

  • May 1, 2026

Related Content

Holistic care in inflammatory bowel disease: is it in REACH?

Gene-Environment Interactions in Inflammatory Bowel Disease: A Systematic Review of Human Epidemiologic Studies

Disruption of Epithelial Barrier Integrity via Altered GILZ/c-Rel/RACK1 Signaling in Inflammatory Bowel Disease